Décision N°0313/D/MINSANTE du 22 FEV 2023
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Décision N°0313/D/MINSANTE du 22 FEV 2023 is the official MINSANTE identifier for “Décision fixant les modalités d’obtention des visas techniques d’importation et d’exportation des produits pharmaceutiques”. Décision N°0313/D/MINSANTE du 22 FEV 2023 is the official identifier MINSANTE uses for this instrument.
- Instrument
- Décision
- Full name
- Décision N°0313/D/MINSANTE du 22 FEV 2023
- Category
- Registration
- Source publication
- French
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Décision fixant les modalités d’obtention des visas techniques d’importation et d’exportation des produits pharmaceutiques
Complete signed two-page Decision0313/D/MINSANTE of22February2023 including Articles1–8. DirectMD evidence is the explicit valid medical-device wholesale-authorization alternative inArticle3(2). The instrument otherwise uses pharmaceutical-product terms; broader medicine-style fields are preserved as source text without asserting new universalMD/IVD duties. Article7 concerns internationally controlled medicines, not a general medical-device obligation. The official procedure index, HTMLarticle and signedPDF are three representations/discovery sources for one instrument; onlyPDF registered. Relationship to2020D36-65importcontrolcircular and subsequent amendments/currentness remains unresolved. Webpage24March2023 and directory24February2023 are not substituted for the printed signed date.
Décision N°0313/D/MINSANTE du 22 FEV 2023 is the official identifier MINSANTE uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.